Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Freeze-Dried Human Rabies Vaccine (Vero Cell) in Healthy Subjects
NCT07672626Phase 3Completed
- Sponsor
- Jiangsu Provincial Center for Disease Control and Prevention
- Start
- Jul 2022
- Primary completion
- Aug 2024
- Countries
- 1
01
Overview
A Phase 3 trial of Freeze-dried Human Rabies Vaccine (Vero cell) in rabies, sponsored by Jiangsu Provincial Center for Disease Control and Prevention. Started Jul 2022; status: completed.
02
Drugs
Freeze-dried Human Rabies Vaccine (Vero cell)
03
Conditions
rabies
Beyond the preview
Go deeper on NCT07672626.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07672626.